Literature DB >> 22342299

Interleaved carbon minibeams: an experimental radiosurgery method with clinical potential.

F Avraham Dilmanian1, Adam Rusek, Giovanna R Fois, John Olschowka, Nicolle R Desnoyers, Jane Y Park, Istvan Dioszegi, Bari Dane, Ruiliang Wang, Dardo Tomasi, Hedok Lee, Sean D Hurley, Patricia K Coyle, Allen G Meek, M Kerry O'Banion.   

Abstract

PURPOSE: To evaluate the efficacy of "interleaved carbon minibeams" for ablating a 6.5-mm target in a rabbit brain with little damage to the surrounding brain. The method is based on the well-established tissue-sparing effect of arrays of thin planes of radiation. METHODS AND MATERIALS: Broad carbon beams from the National Aeronautics and Space Agency Space Radiation Facility at Brookhaven National Laboratory were segmented into arrays of parallel, horizontal, 0.3-mm-thick planar beams (minibeams). The minibeams' gradual broadening in tissues resulted in 0.525-mm beam thickness at the target's proximal side in the spread-out Bragg peak. Interleaving was therefore implemented by choosing a 1.05 mm beam spacing on-center. The anesthetized rabbit, positioned vertically on a stage capable of rotating about a vertical axis, was exposed to arrays from four 90° angles, with the stage moving up by 0.525 mm in between. This produced a solid radiation field at the target while exposing the nontargeted tissues to single minibeam arrays. The target "physical" absorbed dose was 40.2 Gy.
RESULTS: The rabbit behaved normally during the 6-month observation period. Contrast magnetic resonance imaging and hematoxylin and eosin histology at 6 months showed substantial focal target damage with little damage to the surrounding brain.
CONCLUSION: We plan to evaluate the method's therapeutic efficacy by comparing it with broad-beam carbon therapy in animal models. The method's merits would combine those of carbon therapy (i.e., tight target dose because of the carbon's Bragg-peak, sharp dose falloff, and high relative biological effectiveness at the target), together with the method's low impact on the nontargeted tissues. The method's smaller impact on the nontargeted brain might allow carbon therapy at higher target doses and/or lower normal tissue impact, thus leading to a more effective treatment of radioresistant tumors. It should also make the method more amenable to administration in either a single dose fraction or in a small number of fractions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342299     DOI: 10.1016/j.ijrobp.2011.12.025

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis.

Authors:  Andrew N Fontanella; Mary-Keara Boss; Michael Hadsell; Jian Zhang; Thies Schroeder; Katherine G Berman; Mark W Dewhirst; Sha Chang; Gregory M Palmer
Journal:  Radiat Res       Date:  2015-01-09       Impact factor: 2.841

2.  Minibeam therapy with protons and light ions: physical feasibility and potential to reduce radiation side effects and to facilitate hypofractionation.

Authors:  F Avraham Dilmanian; John G Eley; Sunil Krishnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-11       Impact factor: 7.038

3.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

4.  Rat sensorimotor cortex tolerance to parallel transections induced by synchrotron-generated X-ray microbeams.

Authors:  Erminia Fardone; Alberto Bravin; Alfredo Conti; Elke Bräuer-Krisch; Herwig Requardt; Domenico Bucci; Geraldine Le Duc; Giuseppe Battaglia; Pantaleo Romanelli
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

5.  Pilot study of neurologic toxicity in mice after proton minibeam therapy.

Authors:  John G Eley; Awalpreet S Chadha; Caio Quini; Elisabeth G Vichaya; Cancan Zhang; James Davis; Narayan Sahoo; Jaylyn Waddell; Dominic Leiser; F Avraham Dilmanian; Sunil Krishnan
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

6.  Beam size limit for pencil minibeam radiotherapy determined from side effects in an in-vivo mouse ear model.

Authors:  Matthias Sammer; Katharina Teiluf; Stefanie Girst; Christoph Greubel; Judith Reindl; Katarina Ilicic; Dietrich W M Walsh; Michaela Aichler; Axel Walch; Stephanie E Combs; Jan J Wilkens; Günther Dollinger; Thomas E Schmid
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

7.  Proton pencil minibeam irradiation of an in-vivo mouse ear model spares healthy tissue dependent on beam size.

Authors:  Matthias Sammer; Esther Zahnbrecher; Sophie Dobiasch; Stefanie Girst; Christoph Greubel; Katarina Ilicic; Judith Reindl; Benjamin Schwarz; Christian Siebenwirth; Dietrich W M Walsh; Stephanie E Combs; Günther Dollinger; Thomas E Schmid
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

Review 8.  Carbon Ion Radiobiology.

Authors:  Walter Tinganelli; Marco Durante
Journal:  Cancers (Basel)       Date:  2020-10-17       Impact factor: 6.575

9.  Optimizing proton minibeam radiotherapy by interlacing and heterogeneous tumor dose on the basis of calculated clonogenic cell survival.

Authors:  Matthias Sammer; Stefanie Girst; Günther Dollinger
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

10.  Charged Particle Therapy with Mini-Segmented Beams.

Authors:  F Avraham Dilmanian; John G Eley; Adam Rusek; Sunil Krishnan
Journal:  Front Oncol       Date:  2015-12-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.